A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Dose-Response Study to Assess the Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity.
Phase of Trial: Phase III
Latest Information Update: 30 Jun 2009
At a glance
- Drugs Topiramate (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Janssen Research & Development
- 31 Aug 2018 Biomarkers information updated
- 23 Jun 2009 Actual patient number (1293) added as reported by ClinicalTrials.gov.
- 30 Dec 2005 New trial record.